A new National Institute of Medicine report says that the National Cancer Institute's Cooperative Group Program — a 50-year-old program that facilitates trials of new cancer treatments — is inefficient and lacks sufficient funding to continue operations as usual.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.